Position in STTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,347,666
+$9,169,124 QoQ
Shares Held
5,957,877
+19.1% QoQ
Ownership
5.94%
of shares outstanding
% of Portfolio
7.12%
of 13F equity value
Holder Rank
#5
of 99 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prosight Management, LP holds $415,390,745 across 22 Biotechnology names. STTK ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LKFT |
Lakefront Biotherapeutics NV
|
2,043,344 | $61,259,453 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
3,804,481 | $58,436,828 | |
| 3 | NKTR |
Nektar Therapeutics
|
810,000 | $56,546,100 | |
| 4 | STTK |
Shattuck Labs, Inc.
This page
|
5,957,877 | $41,347,666 | |
| 5 | INSM |
INSMED Inc
|
375,609 | $40,047,431 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
98,080 | $29,525,022 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
|
1,200,000 | $26,232,000 | |
| 8 | KURA |
Kura Oncology, Inc.
|
2,021,964 | $22,180,945 |
All Filings in STTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,347,666 | 5,957,877 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $32,178,542 | 5,004,439 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,692,482 | 2,381,502 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,028,356 | 5,451,195 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,258,036 | 6,638,935 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,306,988 | 6,638,935 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,033,111 | 6,638,935 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,818,753 | 5,678,726 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,026,200 | 4,670,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,301,500 | 3,725,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,841,342 | 2,782,797 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,226,960 | 2,123,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,582,014 | 2,109,620 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,943,703 | 2,021,668 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,861,033 | 2,113,493 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,026,095 | 1,120,776 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,141,200 | 1,020,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,402,538 | 798,718 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,214,667 | 260,243 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,449,131 | 169,241 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||